Time to Cost-Effectiveness Following Stroke Reduction Strategies in AF
نویسندگان
چکیده
منابع مشابه
Time to Cost-Effectiveness Following Stroke Reduction Strategies in AF: Warfarin Versus NOACs Versus LAA Closure.
BACKGROUND Left atrial appendage closure (LAAC) and nonwarfarin oral anticoagulants (NOACs) have emerged as safe and effective alternatives to warfarin for stroke prophylaxis in patients with nonvalvular atrial fibrillation (AF). OBJECTIVES This analysis assessed the cost-effectiveness of warfarin, NOACs, and LAAC with the Watchman device (Boston Scientific, Marlborough, Massachusetts) for st...
متن کاملCost-effectiveness analysis of alternative cooling strategies following cardiac arrest
OBJECTIVES Using survival and neurologic outcome as endpoints , this study explored the incremental cost effectiveness of three mutually exclusive cooling strategies employed after resuscitated out-of-hospital cardiac arrests. DESIGN Economic analysis based on retrospective data collection and Markov modeling. SETTING Modeling based on patients housed in a tertiary ICU setting. PATIENTS P...
متن کاملCost-Effectiveness of Revascularization€Strategies
Fro Qu Ca Cli Ce Su Aff xxD Yo Un an Me BACKGROUND ASCERT (American College of Cardiology Foundation and the Society of Thoracic Surgeons Collaboration on the Comparative Effectiveness of Revascularization Strategies) was a large observational study designed to compare the long-term effectiveness of coronary artery bypass graft (CABG) and percutaneous coronary intervention (PCI) to treat corona...
متن کاملStroke risk in AF: do AF patterns matter?
Cardiovascular Research Center, Massachusetts General Hospital, Charlestown, MA, USA; Division of Preventive Medicine, Brigham and Women’s Hospital, Boston, MA, USA; Section of Cardiology, Evans Department of Medicine, Boston University School of Medicine, Framingham, MA, USA; Cardiac Arrhythmia Service, Massachusetts General Hospital, Boston, MA, USA; and Preventive Medicine Section, Whitaker ...
متن کاملCost-Effectiveness of Endovascular Stroke Therapy
The currently estimated direct and indirect annual costs of stroke in the United States are $33 billion. Improved therapy is an urgent need not only from a medical perspective but also from an economic point of view. Five randomized controlled trials (RCTs) using latest generation endovascular therapy (EVT) devices (ESCAPE [Endovascular Treatment for Small Core and Proximal Occlusion Ischemic S...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of the American College of Cardiology
سال: 2015
ISSN: 0735-1097
DOI: 10.1016/j.jacc.2015.09.084